Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome, September 2022

Free Subscription


Abstracts

Retrieve all available abstracts of the following 76 articles:
HTML format


 

Single Articles

  1. NARVAEZ KR, Thompson T
    Compounded Medications and Probiotics for Irritable Bowel Syndrome.
    Int J Pharm Compd. 2022;26:378-384.
    PubMed    
    Abstract available

  2. AL-BILTAGI M, El Amrousy D, El Ashry H, Maher S, et al
    Effects of adherence to the Mediterranean diet in children and adolescents with irritable bowel syndrome.
    World J Clin Pediatr. 2022;11:330-340.
    PubMed    
    Abstract available

  3. PAN YY, Deng Y, Su S, Yin JH, et al
    Structure Composition and Intracellular Transport of Clathrin-Mediated Intestinal Transmembrane Tight Junction Protein.
    Inflammation. 2022 Sep 1. pii: 10.1007/s10753-022-01724.
    PubMed    
    Abstract available

  4. DING J, Zheng P, Sun YY, Wang XR, et al
    [Analysis of Wumei Pills in treating chronic digestive system diseases with concept of "treating different diseases with same method" based on network pharmacology and molecular docking].
    Zhongguo Zhong Yao Za Zhi. 2022;47:4164-4176.
    PubMed    
    Abstract available

  5. KUMAR A, Tanwar S, Gupta S, Chetiwal R, et al
    Advanced metastatic pancreatic neuroendocrine tumor treated successfully with peptide receptor radionuclide therapy: a case report.
    Explor Target Antitumor Ther. 2022;3:392-397.
    PubMed    
    Abstract available

  6. CHEN Y, Lian B, Li P, Yao S, et al
    Studies on irritable bowel syndrome associated with anxiety or depression in the last 20 years: A bibliometric analysis.
    Front Public Health. 2022;10:947097.
    PubMed    
    Abstract available

  7. CHOI YJ, Shin SH, Shin HS
    Immunomodulatory Effects of Bifidobacterium spp. and Use of B. breve and B. longum on Acute Diarrhea in Children.
    J Microbiol Biotechnol. 2022;32:1-9.
    PubMed    
    Abstract available

  8. DOROFEYEV A, Dorofeyeva A, Borysov A, Tolstanova G, et al
    Gastrointestinal health: changes of intestinal mucosa and microbiota in patients with ulcerative colitis and irritable bowel syndrome from PM2.5-polluted regions of Ukraine.
    Environ Sci Pollut Res Int. 2022 Aug 30. pii: 10.1007/s11356-022-22710.
    PubMed    
    Abstract available

  9. NOROUZI M, Pirestani M, Arefian E, Dalimi A, et al
    Exosomes secreted by Blastocystis subtypes affect the expression of proinflammatory and anti-inflammatory cytokines (TNFalpha, IL-6, IL-10, IL-4).
    Front Med (Lausanne). 2022;9:940332.
    PubMed    
    Abstract available

  10. ZENG J, Wang X, Pan F, Mao Z, et al
    The relationship between Parkinson's disease and gastrointestinal diseases.
    Front Aging Neurosci. 2022;14:955919.
    PubMed    
    Abstract available

  11. QI LY, Yang JW, Yan SY, She YF, et al
    Effect of acupuncture for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized clinical trial.
    Trials. 2022;23:711.
    PubMed    
    Abstract available

  12. TAN ZE, Tan YQ, Lin H, How CH, et al
    Irritable bowel syndrome: an approach for primary care physicians.
    Singapore Med J. 2022;63:367-370.
    PubMed    


  13. MANIPIS K, Mulhern B, Haywood P, Viney R, et al
    Estimating the willingness-to-pay to avoid the consequences of foodborne illnesses: a discrete choice experiment.
    Eur J Health Econ. 2022 Sep 8. pii: 10.1007/s10198-022-01512.
    PubMed    
    Abstract available

  14. THOMAS A, Thomas A, Butler-Sanchez M
    Dietary Modification for the Restoration of Gut Microbiome and Management of Symptoms in Irritable Bowel Syndrome.
    Am J Lifestyle Med. 2021;16:608-621.
    PubMed    
    Abstract available

  15. ZHAN TT, Dong ZY, Yi LS, Zhang Y, et al
    Tandospirone prevents stress-induced anxiety-like behavior and visceral hypersensitivity by suppressing theta oscillation enhancement via 5-HT1A receptors in the anterior cingulate cortex in rats.
    Front Cell Neurosci. 2022;16:922750.
    PubMed    
    Abstract available

  16. BAO W, Qi L, Bao Y, Wang S, et al
    Alleviating insomnia should decrease the risk of irritable bowel syndrome: Evidence from Mendelian randomization.
    Front Pharmacol. 2022;13:900788.
    PubMed    
    Abstract available

  17. LIU Z, Zhu S, He M, Li M, et al
    Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity.
    Chin Med J (Engl). 2022 Aug 25. pii: 00029330-990000000-00145.
    PubMed    
    Abstract available

  18. XI M, Zhao P, Li F, Bao H, et al
    MicroRNA-16 inhibits the TLR4/NF-kappaB pathway and maintains tight junction integrity in irritable bowel syndrome with diarrhea.
    J Biol Chem. 2022 Sep 3:102461. doi: 10.1016/j.jbc.2022.102461.
    PubMed    
    Abstract available

  19. ALGERA JP, Tornblom H, Simren M
    Treatments targeting the luminal gut microbiota in patients with irritable bowel syndrome.
    Curr Opin Pharmacol. 2022;66:102284.
    PubMed    
    Abstract available

  20. CHU N, Chan JC, Chow E
    A diet high in FODMAPs as a novel dietary strategy in diabetes?
    Clin Nutr. 2022;41:2103-2112.
    PubMed    
    Abstract available

  21. ROSHIDI N, Arifin N
    Disease Biomarkers of Giardiasis.
    J Parasitol Res. 2022;2022:1932518.
    PubMed    
    Abstract available

  22. FRANKLIN F, Rajamanikam A, Raju CS, Gill JS, et al
    Higher amoebic and metronidazole resistant forms of Blastocystis sp. seen in schizophrenic patients.
    Parasit Vectors. 2022;15:313.
    PubMed    
    Abstract available

  23. HUSSEIN H, Boeckxstaens GE
    Immune-mediated food reactions in irritable bowel syndrome.
    Curr Opin Pharmacol. 2022;66:102285.
    PubMed    
    Abstract available

  24. YANG H, Hou C, Xiao W, Qiu Y, et al
    The role of mechanosensitive ion channels in the gastrointestinal tract.
    Front Physiol. 2022;13:904203.
    PubMed    
    Abstract available

  25. DE LAS MERCEDES VILLA ROSERO C, Mazin SC, Nogueira AA, Vargas-Costales JA, et al
    Prevalence of chronic pelvic pain and primary dysmenorrhea in women of reproductive age in Ecuador.
    BMC Womens Health. 2022;22:363.
    PubMed    
    Abstract available

  26. HUBBARD CRISTINACCE PL, Keaveney S, Aboagye EO, Hall MG, et al
    Clinical translation of quantitative magnetic resonance imaging biomarkers - An overview and gap analysis of current practice.
    Phys Med. 2022;101:165-182.
    PubMed    
    Abstract available

  27. FARSI F, Zonooz SR, Ebrahimi Z, Jebraili H, et al
    The Incidence of Post-infectious Irritable Bowel Syndrome, Anxiety, and Depression in Iranian Patients with Coronavirus Disease 2019 Pandemic: A Cross-Sectional Study.
    Turk J Gastroenterol. 2022 Sep 13. doi: 10.5152/tjg.2022.21651.
    PubMed    
    Abstract available

  28. BONAZ B
    Anti-inflammatory effects of vagal nerve stimulation with a special attention to intestinal barrier dysfunction.
    Neurogastroenterol Motil. 2022 Sep 12:e14456. doi: 10.1111/nmo.14456.
    PubMed    
    Abstract available

  29. REJ A, Avery A, Aziz I, Black CJ, et al
    Diet and irritable bowel syndrome: an update from a UK consensus meeting.
    BMC Med. 2022;20:287.
    PubMed    
    Abstract available

  30. WANG K, Liu H, Liu J, Han L, et al
    Factors related to irritable bowel syndrome and differences among subtypes: A cross-sectional study in the UK Biobank.
    Front Pharmacol. 2022;13:905564.
    PubMed    
    Abstract available

  31. LIANG SB, Cao HJ, Kong LY, Wei JL, et al
    Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials.
    Front Pharmacol. 2022;13:904657.
    PubMed    
    Abstract available

  32. LU Q, Tan D, Luo J, Ye Y, et al
    Potential of natural products in the treatment of irritable bowel syndrome.
    Phytomedicine. 2022;106:154419.
    PubMed    
    Abstract available

  33. MENGZHU S, Yujie Z, Yafang S, Jing G, et al
    Electroacupuncture at Tianshu (ST25) and Zusanli (ST36) alleviates stress-induced irritable bowel syndrome in mice by modulating gut microbiota and corticotropin-releasing factor.
    J Tradit Chin Med. 2022;42:732-740.
    PubMed    
    Abstract available

  34. BUREYCHAK T, Faresjo A, Sjodahl J, Norlin AK, et al
    Symptoms and health experience in irritable bowel syndrome with focus on men.
    Neurogastroenterol Motil. 2022 Sep 8:e14430. doi: 10.1111/nmo.14430.
    PubMed    
    Abstract available

  35. ACHAREKAR MV, Guerrero Saldivia SE, Unnikrishnan S, Chavarria YY, et al
    A Systematic Review on the Efficacy and Safety of Selective Serotonin Reuptake Inhibitors in Gastrointestinal Motility Disorders: More Control, Less Risk.
    Cureus. 2022;14:e27691.
    PubMed    
    Abstract available

  36. HOPMANN P, Tan E, Lo D
    Multiseptate gallbladder presenting with biliary colic.
    J Surg Case Rep. 2022;2022:rjac417.
    PubMed    
    Abstract available

  37. LONIEWSKI I, Skonieczna-Zydecka K, Solek-Pastuszka J, Marlicz W, et al
    Probiotics in the Management of Mental and Gastrointestinal Post-COVID Symptomes.
    J Clin Med. 2022;11.
    PubMed    
    Abstract available

  38. RADOS K, Cukelj Mustac N, Varga K, Drakula S, et al
    Development of High-Fibre and Low-FODMAP Crackers.
    Foods. 2022;11.
    PubMed    
    Abstract available

  39. WANG S, Lu J, Yu M, Wang X, et al
    "I'm listening, did it make any difference to your negative emotions?" Evidence from hyperscanning.
    Neurosci Lett. 2022;788:136865.
    PubMed    
    Abstract available

  40. ILYAS F
    Successful low-dose corticosteroid treatment of aggressive pyoderma gangrenosum with irritable bowel syndrome: a case report.
    Acta Dermatovenerol Alp Pannonica Adriat. 2022;31:111-114.
    PubMed    
    Abstract available

  41. ZEESHAN MH, Vakkalagadda NP, Sree GS, Anne KK, et al
    Irritable bowel syndrome in adults: Prevalence and risk factors.
    Ann Med Surg (Lond). 2022;81:104408.
    PubMed    
    Abstract available

  42. ELBADAWI M, Ammar RM, Rabini S, Klauck SM, et al
    Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management.
    Pharmaceuticals (Basel). 2022;15.
    PubMed    
    Abstract available

  43. MAZZAWI T, Hausken T, Refsnes PF, Hatlebakk JG, et al
    The Effect of Anaerobically Cultivated Human Intestinal Microbiota Compared to Fecal Microbiota Transplantation on Gut Microbiota Profile and Symptoms of Irritable Bowel Syndrome, a Double-Blind Placebo-Controlled Study.
    Microorganisms. 2022;10.
    PubMed    
    Abstract available

  44. SKROBISZ K, Piotrowicz G, Rudnik A, Naumczyk P, et al
    Evaluation of Subcortical Structure Volumes in Patients with Non-Specific Digestive Diseases.
    Diagnostics (Basel). 2022;12.
    PubMed    
    Abstract available

  45. HUDSON KE, Grau JW
    Ionic Plasticity: Common Mechanistic Underpinnings of Pathology in Spinal Cord Injury and the Brain.
    Cells. 2022;11.
    PubMed    
    Abstract available

  46. LIU A, Gao W, Zhu Y, Hou X, et al
    Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome.
    Toxins (Basel). 2022;14.
    PubMed    
    Abstract available

  47. SHRESTHA B, Patel D, Shah H, Hanna KS, et al
    The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review.
    Cureus. 2022;14:e28064.
    PubMed    
    Abstract available

  48. AILANI J, Kaiser EA, Mathew PG, McAllister P, et al
    Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review.
    Neurology. 2022 Sep 20. pii: WNL.0000000000201332.
    PubMed    
    Abstract available

  49. STONE AL, Epstein I, Bruehl S, Garber J, et al
    Twenty-year outcomes of a pediatric chronic abdominal pain cohort: Early adulthood health status and offspring physical and behavioral health.
    J Pain. 2022 Sep 17. pii: S1526-5900(22)00405.
    PubMed    
    Abstract available

  50. HE Z, Liu Y, Liu JJ, Shu GF, et al
    PLR and IL-8 were Potential Markers in Differential Diagnosis and Disease Activity in Ulcerative Colitis Patients.
    Clin Lab. 2022;68.
    PubMed    
    Abstract available

  51. STORR M

    MMW Fortschr Med. 2022;164:26-27.
    PubMed    


  52. FRITZ N, Berens S, Dong Y, Martinez C, et al
    The serotonin receptor 3E variant is a risk factor for female IBS-D.
    J Mol Med (Berl). 2022 Sep 19. pii: 10.1007/s00109-022-02244.
    PubMed    
    Abstract available

  53. RUIZ-MALAGON AJ, Rodriguez-Sanchez MJ, Rodriguez-Sojo MJ, Vezza T, et al
    Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats.
    Front Pharmacol. 2022;13:967644.
    PubMed    
    Abstract available

  54. SATO YZ, Hock RA, Garcia RL, Dihowm F, et al
    Burkitt's Lymphoma of the Colon: A Case Report and Review of the Texas Cancer Registry.
    Cureus. 2022;14:e27964.
    PubMed    
    Abstract available

  55. ALKHAYAL A, Alasmari FA, Alomeyr BK, Abumelha S, et al
    Chronic pelvic pain syndrome symptoms significantly affect medical students' well-being.
    Urol Ann. 2022;14:259-264.
    PubMed    
    Abstract available

  56. LIN ZL, Lu JB, Chen QY, Cui JQ, et al
    [Clinical effectiveness of fecal microbiota transplantation combined with nutritional support and psychological intervention in patients with "Tetralogy of Tongji"].
    Zhonghua Wei Chang Wai Ke Za Zhi. 2022;25:784-791.
    PubMed    
    Abstract available

  57. LIU MJ, Yang JY, Yan ZH, Hu S, et al
    Recent findings in Akkermansia muciniphila-regulated metabolism and its role in intestinal diseases.
    Clin Nutr. 2022;41:2333-2344.
    PubMed    
    Abstract available

  58. ASKARI H, Shojaei-Zarghani S, Raeis-Abdollahi E, Jahromi HK, et al
    The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.
    Mini Rev Med Chem. 2022 Sep 14. pii: MRMC-EPUB-126304.
    PubMed    
    Abstract available

  59. ZENG HY, Bai T, Li SE, Zhang L, et al
    Exploration of "Zhang" in functional gastrointestinal disorders: A cross-cultural challenge in Chinese clinical setting.
    J Dig Dis. 2022;23:388-395.
    PubMed    
    Abstract available

  60. ABDELGHAFAR YA, AbdelQadir YH, Motawea KR, Nasr SA, et al
    Efficacy and safety of fecal microbiota transplant in irritable bowel syndrome: An update based on meta-analysis of randomized control trials.
    Health Sci Rep. 2022;5:e814.
    PubMed    
    Abstract available

  61. HOU Y, Zhao Y, Jiang H, Wang K, et al
    Maintenance of Intestinal Homeostasis in Diarrhea-Predominant Irritable Bowel Syndrome by Electroacupuncture Through Submucosal Enteric Glial Cell-Derived S-Nitrosoglutathione.
    Front Physiol. 2022;13:917579.
    PubMed    
    Abstract available

  62. TANG HY, Chen XQ, Wang H, Chu HR, et al
    Acupuncture relieves the visceral pain of diarrhea-predominant irritable bowel syndrome rats by regulating P2X4 expression.
    Am J Transl Res. 2022;14:5563-5573.
    PubMed    
    Abstract available

  63. BADAWY M, Johnson G, Jain M, Kendi AT, et al
    Intracranial neuroendocrine tumour simulating meningioma for several years: an overview of diagnosis and treatment.
    BJR Case Rep. 2022;8:20210222.
    PubMed    
    Abstract available

  64. FORMICA S, Rizzo G, Martino G, Lucifora C, et al
    Relationship Between Sensitivity to Disgust and Irritable Bowel Syndrome: A Study on Healthy Individuals.
    Clin Neuropsychiatry. 2022;19:230-235.
    PubMed    
    Abstract available

  65. TORNKVIST NT, Tornblom H
    European guidelines on functional bowel disorders with diarrhoea: United European Gastroenterology (UEG) and European Society for neurogastroenterology and motility (ESNM) statements and recommendations.
    United European Gastroenterol J. 2022;10:615-616.
    PubMed    


  66. GUGNOWSKA K, Novembre G, Kohler N, Villringer A, et al
    Endogenous sources of interbrain synchrony in duetting pianists.
    Cereb Cortex. 2022;32:4110-4127.
    PubMed    
    Abstract available

  67. ATUH NI, Anong DN, Jerome FC, Oriero E, et al
    High genetic complexity but low relatedness in Plasmodium falciparum infections from Western Savannah Highlands and coastal equatorial Lowlands of Cameroon.
    Pathog Glob Health. 2022;116:428-437.
    PubMed    
    Abstract available

  68. GU Y, Xiang Y
    Letter: efficacy of peppermint oil in irritable bowel syndrome.
    Aliment Pharmacol Ther. 2022;56:1215-1216.
    PubMed    


  69. INGROSSO MR, Ianiro G, Nee J, Lembo AJ, et al
    Letter: efficacy of peppermint oil in irritable bowel syndrome-authors' reply.
    Aliment Pharmacol Ther. 2022;56:1217-1218.
    PubMed    


  70. NORDIN E, Hellstrom PM, Brunius C, Landberg R, et al
    Modest conformity between self-reporting of Bristol stool form and fecal consistency measured by stool water content in irritable bowel syndrome, a FODMAP and gluten trial.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00449.
    PubMed    
    Abstract available

  71. VILLANUEVA-MILLAN MJ, Leite G, Wang J, Morales W, et al
    Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes.
    Am J Gastroenterol. 2022 Sep 6. pii: 00000434-990000000-00500.
    PubMed    
    Abstract available

  72. KESZTHELYI D
    Histamine-producing bacteria: the missing link in irritable bowel syndrome?
    Gastroenterology. 2022 Sep 8. pii: S0016-5085(22)01038.
    PubMed    


  73. BALSIGER LM, Van den Houte K, Zheng T, Toth J, et al
    Genetic analyses of treatment response in primary care IBS, a pilot study.
    Gut. 2022 Sep 23. pii: gutjnl-2022-328430. doi: 10.1136/gutjnl-2022-328430.
    PubMed    


  74. GORKA AM, Nauta F, Bijlsma MW, Taselaar P, et al
    Current treatment practice of functional abdominal pain disorders in children: A multicenter survey.
    Indian J Gastroenterol. 2022 Sep 3. pii: 10.1007/s12664-022-01253.
    PubMed    
    Abstract available

  75. MENON J, Thapa BR, Kumari R, Kadyada SP, et al
    EFFICACY OF ORAL PSYLLIUM IN PEDIATRIC IRRITABLE BOWEL SYNDROME : A DOUBLE BLIND RANDOMISED CONTROL TRIAL.
    J Pediatr Gastroenterol Nutr. 2022 Sep 22. pii: 00005176-990000000-00183.
    PubMed    
    Abstract available

  76. LIU J, Peng R, Tan Q, Li B, et al
    Proteomic analysis of rat colonic mucosa following acupuncture treatment for irritable bowel syndrome with diarrhea.
    PLoS One. 2022;17:e0273853.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;